|emgality fda label||1.32||0.4||2469||55|
|emgality fda approval||0.63||0.2||7136||2|
|emgality fda approval date||1.6||0.9||8265||91|
|emgality fda package insert||0.1||0.4||2262||83|
|emgality fda insert||1.11||1||3499||82|
|emgality fda approved||0.5||0.2||4760||75|
|emgality fda pi||1.03||0.1||6339||22|
|emgality fda indication||0.66||0.7||2264||90|
|emgality fda approval history||0.01||0.8||4063||40|
Important Administration Instructions. Administer Emgality in the abdomen, thigh, back of the upper arm, or buttocks subcutaneously. Do not inject into areas where the skin is tender, bruised, red, or hard. Both the prefilled pen and prefilled syringe are single-dose and deliver the entire contents.How long after injection does Emgality stay in system?
The clusters last anywhere from one week to one year. They're separated by at least three months of pain-free time. Emgality comes as a prefilled pen or syringe that you'll use to give yourself a monthly injection. Emgality contains the drug galcanezumab, which is a monoclonal antibody.What is Emgality used for?
What is Emgality? Emgality is a prescription medicine used in adults for the: preventive treatment of migraine.